Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-14 Purchase | 2024-03-18 4:06 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 4,400 | $11.31 | $49,771 | 171,620 (Direct) | View |
| 2021-12-13 Sale | 2021-12-15 9:48 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 325,377 | $27.36 | $8,901,804 | 2,536,857 (Indirect Direct) | View |
| 2021-12-08 Sale | 2021-12-10 9:22 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 145,637 | $32.26 | $4,698,091 | 2,542,659 (Indirect Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 9:31 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 400,000 | $19 | $7,600,000 | 227,432 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-14 Tax Withholding | 2024-08-16 5:05 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 2,191 | $2.58 | 169,429 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 6:03 pm | N/A 2034-02-13 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 250,000 | $0 | 357,220 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:24 pm | N/A 2033-09-07 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Chief Executive Officer | 1,200,000 | $0 | 1,200,000 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-22 4:46 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 20,200 | $0 | 20,200 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 8:26 pm | N/A 2032-06-14 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 12,004 | $0 | 12,004 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 6:54 pm | N/A 2031-06-10 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director | 12,004 | $0 | 12,004 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 9:31 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 7,537,750 | $0 | 227,432 (Direct) | View |
| 2020-07-16 Option Award | 2020-07-17 7:06 pm | N/A 2030-07-16 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 24,009 | $0 | 24,009 (Direct) | View |
Ownership | 2020-07-16 6:38 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 0 | $0 | 3,757,875 (Direct) | View |